P&G Health News

Dear Sir,Please find enclosed certificate as issued by Company''s PCS confirming compliance as required under Regulation 40(9) of the SEBI (LODR) Regulations. Request you to kindly take note of the same.

Dear Sir,We have issued duplicate share certificate to our shareholder, as detailed in enclosed letter.Request you to kindly take note of the same.

Dear Sir,We have received intimation from our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter. Kindly take the same on record.

Dear Sir,We have been informed by our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter.Request you to kindly take note of the same.

Dear Sir,Please find attached compliance certificate under Regulation 74(5) of the SEBI (DP) Participants Rules, for the quarter ended June 30, 2024. Kindly take the same into record.

Dear Sir,Please find attached confirmation certificate signed by the Company and RTA for compliance done during the Financial year ended June 30, 2024.

We would like to inform you that the Trading Window of the Company shall remain closed from July 1, 2024 until 48 hours from the publication of the audited financial results for the financial year ended June 30, 2024, as further detailed in enclosed letter.

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 21, 2024, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2024 and to consider recommendation of dividend (if any).

Dear Sir,Please be informed that we have issued share certificate to our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.

There has been a typographical error in the share certificate details mentioned in the earlier announcement of even date, in this regard find enclosed revised details with respect to loss of share certificates of shareholders of the Company as intimated by the RTA, Kfin technologies Limited.

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Limited.

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Ltd.

Dear Sir,Please be informed that we have issued duplicate share certificate to our shareholder as per attached letter.Kindly take the same on record.

Find enclosed press release on the unaudited financial results for the quarter ended March 31,2024

Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 and the limited review report of the auditors thereon.

Enclosed herewith are the unaudited financial results for the quarter ended March 31,2024 along with the limited review report of the auditors thereon.

Find enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company

Dear Sir,We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter.Kindly take note of the same.

Dear Sir,We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.

Dear Sir,Please find attached report received from RTA confirming compliance under Regulation 74 of the SEBI (DP) Regulations, 2018. Kindly take the same on record.

Dear Sir,This is to update that we have issued duplicate share certificates to our shareholders as detailed in enclosed letter. Kindly take note of the same.

Dear SirPlease be informed that we have received intimation regarding loss/misplacement of share certificate by our shareholder, as detailed in enclosed letter.

Dear SirWe have received information regarding loss of share certificate, as detailed in enclosed letter.Please take note of the same.

Dear Sir,We have received information regarding loss of share certificate, as detailed in enclosed letter.Request you to kindly take note of the same.

Dear Sir,We have received information related to loss of share certificate, as detailed in enclosed letter. Kindly take note of the same.

Dear Sir,We have received information regarding loss/misplacement of share certificate from our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 2,2024, inter alia, to consider and approve Unaudited Financial Results for the Quarter ended March 31, 2024.

Dear Sir,We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from April 1, 2024 untill 48 hours from date of publication of unaudited financial results for the quarter ended March 31, 2024.Request you to kindly take note of the same.

Dear Sir,We are informed by our Registrar Transfer Agents regarding loss/misplacement of share certificate by our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.